tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Immunovant (IMVT)
NASDAQ:IMVT
US Market
IMVT
Immunovant
Overview
Analyst Forecasts
AI Stock Analysis
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Immunovant (IMVT) Stock News & Sentiment

Compare
815 Followers
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
Premium
Ratings
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
5d ago
IMVT
Immunovant’s Promising Clinical Trial Results and Market Dynamics Drive Buy Rating
Premium
Ratings
Immunovant’s Promising Clinical Trial Results and Market Dynamics Drive Buy Rating
6d ago
IMVT
Immunovant’s Batoclimab Shows Promising Efficacy in MG and CIDP, Justifying Buy Rating
Premium
Ratings
Immunovant’s Batoclimab Shows Promising Efficacy in MG and CIDP, Justifying Buy Rating
6d ago
IMVT
Immunovant Announces Positive Phase 3 Study Results
Premium
Company Announcements
Immunovant Announces Positive Phase 3 Study Results
6d ago
8K
IMVT
Immunovant’s Phase 3 Trial of Batoclimab: A Catalyst for Future Growth and Market Impact
Premium
Ratings
Immunovant’s Phase 3 Trial of Batoclimab: A Catalyst for Future Growth and Market Impact
7d ago
IMVT
Immunovant’s Promising Pipeline and Strategic Focus Drive Buy Rating
Premium
Ratings
Immunovant’s Promising Pipeline and Strategic Focus Drive Buy Rating
26d ago
IMVT
Immunovant’s Promising Outlook: Buy Rating on Phase 3 Batoclimab Data and Strategic Differentiation
Premium
Ratings
Immunovant’s Promising Outlook: Buy Rating on Phase 3 Batoclimab Data and Strategic Differentiation
30d ago
IMVT
More IMVT News >

IMVT News on the Web

Deep Track Capital, LP Acquires Significant Stake in Dianthus Therapeutics Inc
GuruFocus News
Neutral
Immunovant Inc (IMVT) Announces Investor Webcast to Discuss Phase 3 and Phase 2b Study Results
GuruFocus News
Bullish
IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success
Zacks
Bullish
Immunovant data positive for Biohaven, says Deutsche Bank
The Fly
Neutral
Immunovant's batoclimab shows 'impressive' efficacy in MG, says H.C. Wainwright
The Fly
Neutral
Morning Brew: Nvidia's AI Lead Expands, Tesla Faces Show Withdrawal
GuruFocus News
Neutral
Incyte (INCY) Up 2.6% Since Last Earnings Report: Can It Continue?
Zacks
Neutral
Immunovant, Inc. : Among The Stocks With At Least $30 Million In Insider Spending Recently
Yahoo Finance
Neutral

News Score - Last 7 Days

Positive
IMVT
Sector Average
Media Buzz
This Week5 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMVT’s Media Buzz Sentiment?
5 articles about IMVT were published this week. In an average week, 1.75 articles are published.
    What is IMVT’s weekly average amount of articles?
    In an average week, 1.75 articles about IMVT are published.
      What is IMVT’s News Sentiment?
      100% of articles about IMVT were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        PLXProtalix
        DVAXDynavax
        OGNOrganon
        IMVTImmunovant
        RBOTVicarious Surgical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing